ZONALON

This brand name is authorized in United States

Active ingredients

The drug ZONALON contains one active pharmaceutical ingredient (API):

1 Doxepin UNII 3U9A0FE9N5 - DOXEPIN HYDROCHLORIDE

Doxepin is not a central nervous system stimulant nor a monoamine oxidase inhibitor. The current hypothesis is that the clinical effects are due, at least in part, to influences on the adrenergic activity at the synapses so that deactivation of noradrenaline by reuptake into the nerve terminals is prevented. Read about Doxepin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZONALON Cream	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AA12	Doxepin	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 0378-8123